David Liu
Dr David M Liu MD is an Interventional Radiologist with the current appointments of Clinical Professor of Radiology at the University of British. He is board certified in both Canada and the US, and holds appointments at the Vancouver General Hospital, University of British Columbia Hospital and the BC Cancer Agency with a cross appointment in the department of Surgery. Dr Liu received his medical degree from University of Toronto, completed his radiology residency at University of British Columbia, and interventional radiology fellowship at Northwestern Memorial Hospital, and has practiced on both sides of the border. In addition to benchside and clinical research in the fields of novel embolic platforms, ablative technologies and cancer related thromboembolic disease. Dr Liu maintains an active clinical practice interventional oncology practice incorporating all aspects of embolization, ablation, venous access, and palliative therapy in all organ systems. He is the co-founder and co-chair of SHOW, and has been credited with 6 book chapters, over 50 publications, over 100 invited lecture worldwide, and is an active member and inducted fellow of the Society of Interventional Radiology. He had recently been awarded the CIRA award from the Canadian Association of Interventional Radiology (CAIR), in recognition of his extraordinary contribution to the practice of IR in Canada and worldwide. He holds specific interest in the treatment of hepatocellular carcinoma, and metastatic colorectal carcinoma and is actively involved in both translational research and clinical trials.
2026 Sessions
Session 4: IO Face-Off: High-Stakes Debates & Clinical Showdowns
-
Moderator
- David Liu, MD, FSIR, FRCPC
Intermediate Stage HCC: Locoregional Therapy (LRT) + Systemic Therapy vs LRT Alone
-
Speaker
- Siddharth Padia, MD
2.5 cm HCC in Setting of Portal Hypertension: Thermal Ablation vs Histotripsy
-
Speaker
- Mina Makary, MD
- Merve Ozen, MD
Personalized Dosimetry in Y90: Mandatory vs Waste of Time
-
Speaker
- Nima Kokabi, MD
- Robert Lewandowski, MD, FSIR
Cholangiocarcinoma: Systemic Therapy Alone vs Systemic Therapy Plus Y90
-
Speaker
- Sarbajit Mukherjee, MD, MS
- William Rilling, MD, FSIR
Early Stage Lung Cancer: Ablation vs SBRT
-
Speaker
- Scott Genshaft, MD
- Jean-Pierre Obeid, MD
T1a and T1b RCC: Radiation Therapy vs Locoregional Therapy
-
Speaker
- Adeel Kaiser, MD
- Timothy McClure, MD, MS
Painful Spinal Metastases- SBRT vs Ablation + Vertebral Augmentation
-
Speaker
- Jason Levy, MD, FSIR
- Jean-Pierre Obeid, MD